130 related articles for article (PubMed ID: 11882358)
1. Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications.
Tai YT; Podar K; Kraeft SK; Wang F; Young G; Lin B; Gupta D; Chen LB; Anderson KC
Exp Hematol; 2002 Mar; 30(3):212-20. PubMed ID: 11882358
[TBL] [Abstract][Full Text] [Related]
2. The 86-kD subunit of Ku autoantigen mediates homotypic and heterotypic adhesion of multiple myeloma cells.
Teoh G; Urashima M; Greenfield EA; Nguyen KA; Lee JF; Chauhan D; Ogata A; Treon SP; Anderson KC
J Clin Invest; 1998 Mar; 101(6):1379-88. PubMed ID: 9502780
[TBL] [Abstract][Full Text] [Related]
3. Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage.
Tai YT; Teoh G; Lin B; Davies FE; Chauhan D; Treon SP; Raje N; Hideshima T; Shima Y; Podar K; Anderson KC
J Immunol; 2000 Dec; 165(11):6347-55. PubMed ID: 11086072
[TBL] [Abstract][Full Text] [Related]
4. Ku in the cytoplasm associates with CD40 in human B cells and translocates into the nucleus following incubation with IL-4 and anti-CD40 mAb.
Morio T; Hanissian SH; Bacharier LB; Teraoka H; Nonoyama S; Seki M; Kondo J; Nakano H; Lee SK; Geha RS; Yata J
Immunity; 1999 Sep; 11(3):339-48. PubMed ID: 10514012
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of class switching to IgG and IgE by recruitment of the HoxC4 and Oct-1 homeodomain proteins and Ku70/Ku86 to newly identified ATTT cis-elements.
Schaffer A; Kim EC; Wu X; Zan H; Testoni L; Salamon S; Cerutti A; Casali P
J Biol Chem; 2003 Jun; 278(25):23141-50. PubMed ID: 12672812
[TBL] [Abstract][Full Text] [Related]
6. Ku86 is essential in human somatic cells.
Li G; Nelsen C; Hendrickson EA
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):832-7. PubMed ID: 11792868
[TBL] [Abstract][Full Text] [Related]
7. The Membrane-associated form of the DNA repair protein Ku is involved in cell adhesion to fibronectin.
Monferran S; Muller C; Mourey L; Frit P; Salles B
J Mol Biol; 2004 Mar; 337(3):503-11. PubMed ID: 15019772
[TBL] [Abstract][Full Text] [Related]
8. The truncation of Ku86 in human lymphocytes.
Łanuszewska J; Widłak P
Cancer Lett; 2004 Mar; 205(2):197-205. PubMed ID: 15036652
[TBL] [Abstract][Full Text] [Related]
9. Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein.
Muller C; Dusseau C; Calsou P; Salles B
Oncogene; 1998 Mar; 16(12):1553-60. PubMed ID: 9569022
[TBL] [Abstract][Full Text] [Related]
10. Transient association of Ku with nuclear substrates characterized using fluorescence photobleaching.
Rodgers W; Jordan SJ; Capra JD
J Immunol; 2002 Mar; 168(5):2348-55. PubMed ID: 11859125
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Ku expression in normal murine B cells by stimuli that promote switch recombination.
Zelazowski P; Max EE; Kehry MR; Snapper CM
J Immunol; 1997 Sep; 159(6):2559-62. PubMed ID: 9300672
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of Ku70/86 expression of breast cancer tissues.
Someya M; Sakata K; Matsumoto Y; Satoh M; Narimatsu H; Hareyama M
Oncol Rep; 2007 Dec; 18(6):1483-7. PubMed ID: 17982634
[TBL] [Abstract][Full Text] [Related]
13. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres.
Espejel S; Franco S; Rodríguez-Perales S; Bouffler SD; Cigudosa JC; Blasco MA
EMBO J; 2002 May; 21(9):2207-19. PubMed ID: 11980718
[TBL] [Abstract][Full Text] [Related]
14. Early decrease in dna repair proteins, Ku70 and Ku86, and subsequent DNA fragmentation after transient focal cerebral ischemia in mice.
Kim GW; Noshita N; Sugawara T; Chan PH
Stroke; 2001 Jun; 32(6):1401-7. PubMed ID: 11387505
[TBL] [Abstract][Full Text] [Related]
15. Heat shock factor 1, an inhibitor of non-homologous end joining repair.
Kang GY; Kim EH; Lee HJ; Gil NY; Cha HJ; Lee YS
Oncotarget; 2015 Oct; 6(30):29712-24. PubMed ID: 26359349
[TBL] [Abstract][Full Text] [Related]
16. Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies.
Holgersson A; Erdal H; Nilsson A; Lewensohn R; Kanter L
Exp Mol Pathol; 2004 Aug; 77(1):1-6. PubMed ID: 15215044
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle.
Muñoz P; Zdzienicka MZ; Blanchard JM; Piette J
Mol Cell Biol; 1998 Oct; 18(10):5797-808. PubMed ID: 9742097
[TBL] [Abstract][Full Text] [Related]
18. Senescent human fibroblasts have elevated Ku86 proteolytic cleavage activity.
Jeng YW; Chao HC; Chiu CF; Chou WG
Mutat Res; 1999 Dec; 435(3):225-32. PubMed ID: 10606813
[TBL] [Abstract][Full Text] [Related]
19. Ku80 can translocate to the nucleus independent of the translocation of Ku70 using its own nuclear localization signal.
Koike M; Ikuta T; Miyasaka T; Shiomi T
Oncogene; 1999 Dec; 18(52):7495-505. PubMed ID: 10602508
[TBL] [Abstract][Full Text] [Related]
20. Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.
Shao CJ; Fu J; Shi HL; Mu YG; Chen ZP
J Neurooncol; 2008 Aug; 89(1):27-35. PubMed ID: 18415044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
